Pain Management Devices Market By Product (Radiofrequency Ablation, Neurostimulation), By Application (Cancer, Neuropathic), and By Region - Trends, Analysis, and Forecast till 2034

Report Code: PMI455720 | Publish Date: February 2024 | No. of Pages: 170

Global Pain Management Devices Market Companies

  • Abbott Laboratories
  • B Braun Melungeon AG
  • Baxter International Inc.
  • Boston Scientific Corp.
  • DJO Global LLC.
  • Johnson & Johnson (Codman And Shurtleff, Inc.,)
  • Kimberly Clark Corporation
  • Medtronic Plc.
  • Pfizer, Inc.
  • Stryker Corp

Recent News:

  • In December 2022, Abbott introduced the world's smallest rechargeable and implantable spinal cord stimulation system: the FDA-approved Eterna Spinal Cord Stimulation System (SCS) for the treatment of chronic pain.
  • In February 2022, Boston Scientific Corporation acquired Baylis Medical Company, Inc. This acquisition expands Boston Scientific's cardiac electrophysiology and structural product portfolio, including the VersaCross Trans septal and NRG radiofrequency platforms as well as expanders used to enable access to the left heart.
  • In January 2022, Medtronic plc, a medical technology company, said it had received approval from the U.S. Food and Drug Administration (FDA) for the Vanta neurostimulator, not refills and the Intellis neurostimulators, rechargeable for the treatment of frequently associated pain. with diabetic peripheral neuropathy (DPN)